CureDuchenne Hosts Conversation with Pfizer to Discuss Opening of First U.S. Sites in Phase 3 Trial of Investigational Gene Therapy for Ambulatory Patients with Duchenne Muscular Dystrophy

/PRNewswire/ -- CureDuchenne, a leading global nonprofit focused on finding and funding a cure for Duchenne muscular dystrophy (DMD), today released a webinar...

Related Keywords

Prnewswire Cureduchenne ,Debra Miller ,Beth Belluscio ,Pfizer ,Global Clinical Lead ,Rare Neurological Diseases ,Bamboo Therapeutics ,Cureduchenne Founder ,Cureduchenne ,